Influence of Metastatic Status and Number of Removed Lymph Nodes on Survival of Patients With Squamous Esophageal Carcinoma

被引:18
作者
Feng Yuan [1 ]
Zheng Qingfeng [1 ]
Wang Jia [1 ]
Lv Chao [1 ]
Yan Shi [1 ]
Wang Yuzhao [1 ]
An Chao [1 ]
Yang Yue [1 ]
机构
[1] Peking Univ, Dept Thorac Surg 2, Lab Carcinogenesis & Translat Res, Sch Oncol,Beijing Canc Hosp & Inst,Minist Educ, Beijing 100142, Peoples R China
关键词
PROGNOSTIC-FACTORS; PREDICTS SURVIVAL; CANCER; ADENOCARCINOMA; LYMPHADENECTOMY; CLASSIFICATION; SURGERY; THERAPY; TUMOR;
D O I
10.1097/MD.0000000000001973
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this study was to determine the impact of lymph node (LN) metastasis conditions on the prognosis of patients with esophageal squamous carcinoma and the minimum number of LNs that should be removed to maximize overall postoperative survival among patients with this specific pathologic subtype.In this study, 312 patients with thoracic squamous esophageal carcinoma who received in-patient thoracic surgery by the same surgeon in our hospital from August 1, 2003 to December 31, 2009 were recruited. Subsequently, Kaplan-Meier methods were used to determine associations between LN metastasis conditions and mortality and between the numbers of LNs removed during esophagectomy and mortality. Cox regression models were used to adjust for potential confounding covariates.According to Kaplan-Meier analyses, the number of metastatic LNs was a good predictor for the prognosis of patients with esophageal squamous carcinoma and the dissection of 29 LNs during thoracic surgery significantly improved patient survival (P=0.011).Lymph node metastasis rates may be a significant predictor for the prognosis of patients with esophageal squamous carcinoma. The number of LNs removed during esophagectomy is an independent predictor for the survival of patients with esophageal squamous carcinoma with maximal postoperative survival after the removal of 29 LNs.
引用
收藏
页数:5
相关论文
共 25 条
  • [1] Total number of resected lymph nodes predicts survival in esophageal cancer
    Altorki, Nasser K.
    Zhou, Xi Kathy
    Stiles, Brendon
    Port, Jeffrey L.
    Paul, Subroto
    Lee, Paul C.
    Mazumdar, Madhu
    [J]. ANNALS OF SURGERY, 2008, 248 (02) : 221 - 226
  • [2] [Anonymous], CHIN CANC REG ANN RE
  • [3] Staging of esophageal carcinoma:: Length of tumor and number of involved regional lymph nodes.: Are these independent prognostic factors?
    Bollschweiler, Elfriede
    Baldus, Stephan E.
    Schroeder, Wolfgang
    Schneider, Paul M.
    Hoelscher, Arnulf H.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2006, 94 (05) : 355 - 363
  • [4] Collard JL, 2001, CANCER, V91, P1098, DOI 10.1002/1097-0142(20010315)91:6<1098::AID-CNCR1105>3.3.CO
  • [5] 2-E
  • [6] Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database
    Corley, DA
    Buffler, PA
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2001, 30 (06) : 1415 - 1425
  • [7] Edge S., 2010, AJCC CANC STAGING MA
  • [8] Determination of the minimum number of lymph nodes to examine to maximize survival in patients with esophageal carcinoma: Data from the Surveillance Epidemiology and End Results database
    Groth, Shawn S.
    Virnig, Beth A.
    Whitson, Bryan A.
    Defor, Todd E.
    Li, Zhong-ze
    Tuttle, Todd M.
    Maddaus, Michael A.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2010, 139 (03) : 612 - 620
  • [9] PROGNOSTIC FACTORS OF RESECTED ADENOCARCINOMA OF THE ESOPHAGUS
    HOLSCHER, AH
    BOLLSCHWEILER, E
    BUMM, R
    BARTELS, H
    HOFLER, H
    SIEWERT, JR
    [J]. SURGERY, 1995, 118 (05) : 845 - 855
  • [10] JEMAL A, 2011, CA-CANCER J CLIN, V61, P69, DOI DOI 10.3322/CAAC.20107